Prevalence, pathogenesis, and impact of atrial fibrillation

American Journal of Health-System Pharmacy

Volumn 67, Issue 9 SUPPL. 5, 2010, Pages

  Sanoski, Cynthia A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Age; Atrial fibrillation; Economics; Epidemiology; Geriatrics; Mortality

Indexed keywords

CONFERENCE PAPER; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; VALVULAR HEART DISEASE; AGED; ARTICLE; CASE REPORT; ECONOMICS; FEMALE; HEALTH CARE COST; HEART INFARCTION; STATISTICS; STROKE; THROMBOEMBOLISM; UNITED STATES;

AGED; ATRIAL FIBRILLATION; FEMALE; HEALTH CARE COSTS; HEART FAILURE; HUMANS; MYOCARDIAL INFARCTION; PREVALENCE; RISK FACTORS; STROKE; THROMBOEMBOLISM; UNITED STATES;

EID: 77954943919     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp100148     Document Type: Conference Paper

References (25)

1. Lloyd-Jones D, Adams RJ, Brown TM et al. Heart disease and stroke statistics 2010 update: a report from the American Heart Association. Circulation. 2010; 121:e1-170. http://circ.ahajournals.org/cgi/reprint/ CIRCULATIONAHA.109.192667 (accessed 2010 Feb 11).
2. Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001; 285:2370-5. (Pubitemid 32424106)
3. Naccarelli GV, Varker H, Lin J et al. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol. 2009; 104:1534-9.
4. Miyasaka Y, Barnes ME, Gersh BJ et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006; 114:119-25.
5. Go AS. The epidemiology of atrial fibrillation in elderly persons: the tip of the iceberg. Am J Geriatr Cardiol. 2005; 14:56-61.
6. Feinberg WM, Blackshear JL, Laupacis A et al. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med. 1995; 155:469-73.
7. Lloyd-Jones DM, Wang TJ, Leip EP et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004; 110:1042-6. (Pubitemid 39319000)
8. Schnabel RM, Sullivan LM, Levy D et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort. Lancet. 2009; 373:739-45.
9. Fuster V, Rydén LE, Cannom DS et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Circulation. 2006; 114:e257-e354.
10. Makkar KM, Sanoski CA, Spinler SA. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias. Pharmacotherapy. 2009; 29:31-48.
11. Isaac TT, Dokainish H, Lakkis M. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol. 2007; 50:2021-8. (Pubitemid 350087568)
12. Wang TJ, Parise H, Levy D et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004; 292:2471-7. (Pubitemid 39552671)
13. Gami AS, Hodge DO, Herges RM et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol. 2007; 49:565-71. (Pubitemid 46177437)
14. Singer DE, Albers GW, Dalen JE et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest. 2008; 133(6 suppl):546S-92S.
15. Gage BF, Waterman AD, Shannon W et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001; 285:2864-70. (Pubitemid 32537350)
16. Miyasaka Y, Barnes ME, Bailey KR et al. Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study. J Am Coll Cardiol. 2007; 49:986-92.
17. Henriksson KM, Farahmand B, Johansson S et al. Survival after stroke: the impact of CHADS(2) score and atrial fibrillation. Int J Cardiol. 2009 Jan 12. [Epub ahead of print].
18. Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation. 2009; 119:2516-25.
19. Dries DL, Exner DV, Gersh BJ et al. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 1998; 32:695-703. (Pubitemid 28435256)
20. Ahmed A, Perry GJ. Incident atrial fibrillation and mortality in older adults with heart failure. Eur J Heart Fail. 2005; 7:1118-21. (Pubitemid 41721113)
21. Schmitt J, Duray G, Gersh BJ et al. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009; 30:1038-45.
22. Wattigney WA, Mensah GA, Croft JB. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. Circulation. 2003; 108:711-6.
23. Miyasaka Y, Barnes ME, Gersh BJ et al. Changing trends of hospital utilization in patients after their first episode of atrial fibrillation. Am J Cardiol. 2008; 102:568-72.
24. Coyne KS, Paramore C, Grandy S et al. Assessing the direct costs of treating non-valvular atrial fibrillation in the United States. Value Health. 2006; 9:348-56. (Pubitemid 44337788)
25. Kim MH, Lin J, Hussein M et al. Cost of atrial fibrillation in United States managed care organizations. Adv Ther. 2009; 26:847-57.